Avraham Pharmaceuticals' Series B Round

Avraham Pharmaceuticals raised a round of funding on November 14, 2011.

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 …

Articles about Avraham Pharmaceuticals' Series B Round: